======= AGGF1 ======= == Gene Information == * **Official Symbol**: AGGF1 * **Official Name**: angiogenic factor with G-patch and FHA domains 1 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=55109|55109]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q8N302|Q8N302]] * **Interactions**: [[https://thebiogrid.org/search.php?search=AGGF1&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20AGGF1|Open PubMed]] * **OMIM**: [[https://omim.org/entry/608464|Open OMIM]] == Function Summary == * **Entrez Summary**: This gene encodes an angiogenic factor that promotes proliferation of endothelial cells. Mutations in this gene are associated with a susceptibility to Klippel-Trenaunay syndrome. Pseudogenes of this gene are found on chromosomes 3, 4, 10 and 16.[provided by RefSeq, Sep 2010]. * **UniProt Summary**: Promotes angiogenesis and the proliferation of endothelial cells. Able to bind to endothelial cells and promote cell proliferation, suggesting that it may act in an autocrine fashion. {ECO:0000269|PubMed:14961121}. |G-patch 2| |FHA| |G-patch| |vasculogenesis| |positive regulation of endothelial cell proliferation| |regulation of endothelial cell proliferation| |positive regulation of angiogenesis| |positive regulation of vasculature development| |positive regulation of epithelial cell proliferation| |nucleic acid binding| |regulation of angiogenesis| |angiogenesis| |regulation of vasculature development| |regulation of epithelial cell proliferation| |blood vessel morphogenesis| |blood vessel development| |vasculature development| |cardiovascular system development| |tube morphogenesis| |perinuclear region of cytoplasm| |tube development| |circulatory system development| |anatomical structure formation involved in morphogenesis| |positive regulation of cell population proliferation| |cell adhesion| |biological adhesion| |regulation of anatomical structure morphogenesis| |positive regulation of developmental process| |regulation of cell population proliferation| |positive regulation of multicellular organismal process| |extracellular region| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp162|BI-D1870 2μM R04 exp162]]|-2.33| |[[:results:exp149|SB203580 25μM R03 exp149]]|-2.2| |[[:results:exp211|AICAR 240μM R05 exp211]]|-2.13| |[[:results:exp426|FBS-Wisent 0.1 R07 exp426]]|-1.78| |[[:results:exp536|Vitamin-D3 40μM R08 exp536]]|1.7| |[[:results:exp465|Cannabidiol 13μM R08 exp465]]|1.74| |[[:results:exp107|UMK57 0.6μM R03 exp107]]|1.75| |[[:results:exp524|Staurosporine 0.02μM R08 exp524]]|1.76| |[[:results:exp81|Selumetinib 20μM R02 exp81]]|1.92| |[[:results:exp61|YM155 0.0002μM R01 exp61]]|2.05| |[[:results:exp442|Ibrutinib 10μM R08 exp442]]|2.17| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 19069 * **Expression level (log2 read counts)**: 5.46 {{:chemogenomics:nalm6 dist.png?nolink |}}